Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae:: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003)

被引:30
作者
DiPersio, JR
Deshpande, LM
Biedenbach, DJ [1 ]
Toleman, MA
Walsh, TR
Jones, RN
机构
[1] JIM Labs, JONES Grp, N Liberty, IA 52317 USA
[2] Summa Hlth Syst, Dept Pathol, Akron, OH USA
[3] Univ Bristol, Sch Med, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
extended-spectrum beta-lactamase; Klebsiella pneunioniae; SENTRY Antimicrobial Surveillance Program;
D O I
10.1016/j.diagmicrobio.2004.08.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
During 2001, occurrences of extended-spectrum beta-lactamase (ESBL) -producing Klebsiella pneunioniae isolates were detected in a single medical center (Hospital A) from the SENTRY Antimicrobial Surveillance Program that became endemic in long-term acute care areas and in the intensive care unit in 2002-2003. Between 2001 and 2003, 123 patients were infected or colonized with ESBL-positive K. pneumoniae. Resistance profiles were determined by reference broth microdilution methods, and automated ribotyping and pulsed-field gel electrophoresis (PFGE) were performed. The ESBL-positive K. pneumoniae isolates were resistant to aztreonam, ceftazidime, aminoglycosides, and trimethoptim/sulfamethoxazole and susceptible to ciprofloxacin and tetracycline. In 1997, 1998, and 2000, 9 ESBL-producing,&.'. pneumoniae strains from 2 New York City hospitals shared the same antibiograms and ribotype (204.2) as the strains from Hospital A. PFGE patterns divided Hospital A isolates into 2 subtypes (A and A,) and 3 New York City strains were similar to the Hospital A isolates (A(2), A(3), and A(4))Isoelectric focusing studies of I New York City isolate (A4) revealed pIs at 5.4, 7.7, and 8.2. PCR and sequencing results from I strain of each Hospital A and I New York PFGE pattern determined that TEM-1 and SHV-5 (ESBL) were present in all strains. In addition, 2 New York isolates from 1998 (A3 and A4) also had an OXA-2 enzyme. ESBL-producing K. pneumoniae isolates with ribotype 204.2 from SENTRY Program sites have been recognized in New York only since 1997 and in Hospital A beginning in 2001. The similarities of the antibiogram and epidemiological patterns suggest that these isolates have persisted over time and may have evolved into different but genetically related endemic ESBL-positive K. pneunmoniae clones that have the ability to cause sustained epidemic outbreaks in US medical centers. (C) 2005 Published by Elsevier Inc.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 34 条
  • [1] [Anonymous], 2003, NCCLS Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, V6th
  • [2] Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers
    Arpin, C
    Dubois, V
    Coulange, L
    André, C
    Fischer, I
    Noury, P
    Grobost, F
    Brochet, JP
    Jullin, J
    Dutilh, B
    Larribet, G
    Lagrange, I
    Quentin, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) : 3506 - 3514
  • [3] SPREAD OF KLEBSIELLA-PNEUMONIAE PRODUCING SHV-5 BETA-LACTAMASE AMONG HOSPITALIZED-PATIENTS
    BAUERNFEIND, A
    ROSENTHAL, E
    EBERLEIN, E
    HOLLEY, M
    SCHWEIGHART, S
    [J]. INFECTION, 1993, 21 (01) : 18 - 22
  • [4] NUCLEOTIDE-SEQUENCE OF THE SHV-5 BETA-LACTAMASE GENE OF A KLEBSIELLA-PNEUMONIAE PLASMID
    BILLOTKLEIN, D
    GUTMANN, L
    COLLATZ, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) : 2439 - 2441
  • [5] Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610
  • [6] Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen
    Cormican, MG
    Marshall, SA
    Jones, RN
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) : 1880 - 1884
  • [7] Clinical and bacteriologic epidemiology of extended-spectrum β-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit
    Decré, D
    Gachot, B
    Lucet, JC
    Arlet, G
    Bergogne-Bérézin, E
    Régnier, B
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) : 834 - 844
  • [8] Molecular epidemiology of selected multidrug-resistant bacteria: A global report from the SENTRY Antimicrobial Surveillance Program
    Deshpande, LM
    Fritsche, TR
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 49 (04) : 231 - 236
  • [9] Antimicrobial resistance trends and outbreak frequency in United States hospitals
    Diekema, DJ
    BootsMiller, BJ
    Vaughn, TE
    Woolson, RF
    Yankey, JW
    Ernst, EJ
    Flach, SD
    Ward, MM
    Franciscus, CLJ
    Pfaller, MA
    Doebbeling, BN
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (01) : 78 - 85
  • [10] Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals
    Edelstein, M
    Pimkin, M
    Palagin, I
    Edelstein, I
    Stratchounski, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3724 - 3732